OmniAb Investor Conference Presentation Deck
Management
Matt Foehr
Chief Executive Officer
Board Member Viking Therapeutics
Former Exec at Ligand Pharmaceuticals,
GlaxoSmithKline,
Stiefel Labs, Connetics Corp.
Bill Harriman, PhD
SVP, Antibody Discovery
Co-Founder/CSO, Crystal Bioscience
Trellis, Roche, Abgenix
UCSF-Immunology, Haas MBA
Kurt Gustafson
Chief Financial Officer
Board Member Xencor, Inc
Former CFO/Exec at
Spectrum Pharmaceuticals,
Halozyme Therapeutics, Amgen
Christel Iffland, PhD
SVP, Antibody Technologies
Former Associate Director at Merck KGaA /
EMD Serono, Co-inventor of Avelumab
Dana Farber, Albert Einstein College
Charles Berkman
Chief Legal Officer
Former General Counsel
at Ligand Pharmaceuticals,
Attorney at Baker & McKenzie,
Lyon & Lyon
Marie-Cecile Van De Lavoir, PhD, DVM
SVP, Technical Operations & Genetics
Co-Founder/COO, Crystal Bioscience
Origen Therapeutics, Inventor Germ Cell Technology
Fulbright Scholar, UCSF, Utrecht, Guelph, Cornell
34
Doug Krafte, PhD
SVP, Ion Channels
Former Exec at Icagen, Pfizer Pain & Sensory
Disorders, Boehringer Ingelheim, Aurora Biosciences
Univ. Rochester, Vanderbilt
OmniAbView entire presentation